New ESC Guidelines for the management of cardiovascular disease in patients with diabetes released

Patients with type 2 diabetes are more than twice as likely to develop cardiovascular disease (CVD) than their healthy peers.

athenahealth Launches AI-Powered Ambient Notes for Ambulatory Practices

What You Should Know: – athenahealth, a prominent provider of network-enabled software for healthcare practices, has announced the limited release of *Ambient Notes*, an AI-driven tool

October 30, 2024

MarketingRx roundup: Pfizer jumps on latest TikTok trend; Novo recruits for CagriSema trial across languages

Pfizer employees take on TikTok trend: Pfizer scientists and social media managers are jumping on the current “We Are” TikTok trend in which people give humorous

March 6, 2024

J&J psoriasis drug licensed from Protagonist doesn’t top competition in Phase IIb trial

Johnson & Johnson’s oral IL-23 that it licensed from Protagonist Therapeutics appears to be a weaker psoriasis treatment than some of its injectable competition, according

July 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.